ABBV vs ASML: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and ASML Holding N.V. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-15.
AbbVie Inc. · Healthcare
$261.07
+1.2% upside to fair value
Grade C
High Quality
VS
ASML Holding N.V. · Technology
$1,775.64
+45.0% upside to fair value
Grade B
High Quality
QuantHub Verdict
ASML has more upside to fair value
(+45.0%).
ASML trades at a lower forward P/E
(62.1x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
ASML |
| Current Price |
$261.07 |
$1,775.64 |
| Fair Value Estimate |
$264.30 |
$2,574.68 |
| Upside to Fair Value |
+1.2%
|
+45.0%
|
| Market Cap |
$461.3B |
$684.4B |
| Forward P/E |
128.0x
|
62.1x
|
| EV / EBITDA |
31.0x
|
47.1x
|
| Price / Sales |
7.3x
|
18.4x
|
| Price / FCF |
22.1x
|
69.1x
|
| Revenue Growth YoY |
+12.4%
|
+13.2%
|
| Gross Margin |
70.7%
|
52.6%
|
| Operating Margin |
27.6%
|
34.8%
|
| Return on Equity |
68.0%
|
52.0%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.52%
|
1.45%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie Inc. is a leading healthcare company specializing in drug manufacturing with a strong focus on immunology and aesthetics. The company is transitioning from its historical Humira dominance, which has faced loss of exclusivity, toward high-growth assets like Skyrizi and Rinvoq that are driving robust revenue growth of 12.4% in the most recent quarter. Despite strong revenue growth and a dura…
ASML Holding N.V. is a leading semiconductor equipment manufacturer specializing in photolithography systems critical for chip production. The company exhibits high business quality with a durable competitive moat supported by advanced technology and strong market position, reflected in a 52% return on equity and robust margins including a 52.6% gross margin and 29.7% net margin. Despite strong r…
Accumulation Zones
| Metric |
ABBV |
ASML |
| Zone Low |
$198.23 |
$1,931.01 |
| Zone High |
$224.66 |
$2,188.48 |
| In Buy Zone? |
No
|
Yes
|